UiPath (PATH)
(Delayed Data from NYSE)
$11.41 USD
-0.39 (-3.31%)
Updated Aug 2, 2024 04:00 PM ET
After-Market: $11.32 -0.09 (-0.79%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth D Momentum C VGM
Brokerage Reports
0 items in cart
UiPath, Inc. [PATH]
Reports for Purchase
Showing records 61 - 80 ( 130 total )
Company: UiPath, Inc.
Industry: Technology Services
Solid 7% F1Q ARR Beat (+64% Y/Y) Post IPO; Reiterate Overweight
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: UiPath, Inc.
Industry: Technology Services
Company: UiPath, Inc.
Industry: Technology Services
Company: UiPath, Inc.
Industry: Technology Services
Initiating RPA & Enterprise Automation Leader at OW
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: UiPath, Inc.
Industry: Medical - Products
Company: UiPath, Inc.
Industry: Medical - Products
February and 2014 Catalysts for Emerging Pharmaceuticals
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: UiPath, Inc.
Industry: Medical - Products
February and 2014 Catalysts for Emerging Pharmaceuticals
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: UiPath, Inc.
Industry: Medical - Products
Downgrading to NEUTRAL and Reducing Our FV to $5 as PATH is Likely to Trade In line with TEVA- TEVA Looks to be the Winner
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: UiPath, Inc.
Industry: Medical - Products
The Week Ahead in Life Sciences - Upcoming Events for the Week of Dec. 9
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: UiPath, Inc.
Industry: Medical - Products
December 2013 Catalysts for Emerging Pharmaceuticals
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: UiPath, Inc.
Industry: Medical - Products
December 2013 Catalysts for Emerging Pharmaceuticals
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: UiPath, Inc.
Industry: Medical - Products
The Week Ahead in Life Sciences - Upcoming Events for the Week of Nov. 25
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: UiPath, Inc.
Industry: Medical - Products
Q3 Financials: Cash Runway Through Jan. 2014; Awaiting Potential Partnership(s) as Launch Delayed Until After Yearend; Reiterate OUTPERFORM and $8 FV
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: UiPath, Inc.
Industry: Medical - Products
November and Remaining 2013 Catalysts for Emerging Pharmaceuticals
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: UiPath, Inc.
Industry: Medical - Products
November and Remaining 2013 Catalysts for Emerging Pharmaceuticals
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: UiPath, Inc.
Industry: Medical - Products
The Week Ahead in Life Sciences - Upcoming Events for the Week of Oct. 28
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: UiPath, Inc.
Industry: Medical - Products
The Week Ahead in Life Sciences - Upcoming Events
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: UiPath, Inc.
Industry: Medical - Products
Initiation of Adolescent Migraineurs Phase 1 is Part of FDA Post-marketing Requirements
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: UiPath, Inc.
Industry: Medical - Products
Additional US Patent Allowance For Zecuity Further Strengthens Intellectual Property; Reiterate OUTPERFORM
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: UiPath, Inc.
Industry: Medical - Products
Emerging Pharmaceuticals - September and Remaining 2013 Catalysts for Emerging Pharmaceuticals
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L